-
EVALUATION OF THE ROLE OF CLINICAL UNMET NEED IN HEALTH TECHNOLOGY ASSESSMENT DECISION-MAKING OF ONCOLOGY TRIALS WITHOUT DEMONSTRATED OVERALL SURVIVAL BENEFITS DUE TO TREATMENT CROSSOVER
Mar 18, 2026, 21:38 PM -
LABORATORY-BASED MACHINE LEARNING ALGORITHM REDUCES ECONOMIC BURDEN BY ENHANCING DIAGNOSTIC ACCURACY AND CLARITY IN PERIPROSTHETIC JOINT INFECTION
Mar 18, 2026, 21:38 PM -
CHARACTERISTICS OF FDA LETTERS CITING REGULATORY VIOLATIONS INVOLVING PATIENT-REPORTED OUTCOMES, 1997-2025
Mar 18, 2026, 21:38 PM -
COMPARISON OF ROBOTIC-ASSISTED ADRENALECTOMY USING THE DA VINCI SURGICAL SYSTEM WITH LAPAROSCOPIC AND OPEN APPROACHES: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS
Mar 18, 2026, 21:38 PM -
QUANTIFYING EHR DISCONTINUITY IN PRAGMATIC TRIALS: INSIGHTS FROM THE NIDA CTN-074 PRIMARY CARE OPIOID USE DISORDERS TREATMENT (PROUD)STUDY
Mar 18, 2026, 21:38 PM -
DEVELOPING THE FIRST PRAGMATIC DOSE CONVERSION BETWEEN LONG-ACTING AND DAILY GROWTH HORMONE IN PREPUBERTAL CHILDREN WITH IDIOPATHIC SHORT STATURE: A JOINT MODELING METHOD USING REAL-WORLD DATA IN CHINA
Mar 18, 2026, 21:38 PM -
USE OF GLUCAGON-LIKE PEPTIDE 1 AGONISTS (GLP-1RAS) BEFORE BARIATRIC SURGERY IN THE US
Mar 18, 2026, 21:38 PM -
ALIGNMENT OF ESTIMATED ACQUISITION COSTS IN U.S. GENE THERAPY COST EFFECTIVENESS ANALYSES WITH STANDARD PRICE BENCHMARKS
Mar 18, 2026, 21:38 PM -
TRANSFORMING VACCINE AVAILABILITY THROUGH REAL-TIME LAST-MILE VISIBILITY: A SYSTEMS APPROACH TO STRENGTHENING STOCK DATA IN NIGERIAN PHC FACILITIES
Mar 18, 2026, 21:38 PM -
REAL-WORLD DISEASE ACTIVITY AND TREATMENT RESPONSIVENESS AMONG ADULTS WITH RHEUMATOID ARTHRITIS
Mar 18, 2026, 21:38 PM -
IMPACT OF TAFAMIDIS USE IN COLOMBIAN PATIENTS DIAGNOSED WITH ATTR-CM ON HEALTH-RELATED QUALITY OF LIFE DURING TWO YEARS OF FOLLOW-UP: REAL WORLD STUDY IN COLOMBIA
Mar 18, 2026, 21:38 PM -
PATIENT PREFERENCES FOR TREATMENT SELECTION IN NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC): A SYSTEMATIC LITERATURE REVIEW (SLR)
Mar 18, 2026, 21:38 PM -
CAREGIVER IMPACT VALUE FRAMEWORK: UNLOCKING SOCIETAL VALUE
Mar 18, 2026, 21:38 PM -
REAL-WORLD RISK OF ACUTE KIDNEY FAILURE AFTER SACUBITRIL/VALSARTAN VS ARB AMONG ADULTS =65 WITH HEART FAILURE
Mar 18, 2026, 21:38 PM -
REAL-WORLD PRESCRIPTION PATTERNS, ADHERENCE, AND LDL REDUCTION OF PCSK9 INHIBITOR USERS IN CHINA: EVIDENCE FOLLOWING NRDL INCLUSION
Mar 18, 2026, 21:38 PM -
COST-BENEFIT ANALYSIS OF 100% WHEY PEPTIDE-BASED FORMULAS IN US ADULTS RECEIVING HOME ENTERAL NUTRITION
Mar 18, 2026, 21:38 PM -
A TALE OF TWO THRESHOLDS: ADAPTIVE THRESHOLDING WITH ABSTENTION FOR AI-ASSISTED SINGLE SCREENING (AISS)
Mar 18, 2026, 21:38 PM -
BUDGET IMPACT OF THE KINCISE 2 SYSTEM COMPARED TO MANUAL IMPACTION IN PATIENTS UNDERGOING PRIMARY TOTAL HIP ARTHROPLASTY IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
MODELING THE COST-EFFECTIVENESS OF RISK-STRATIFIED SCREENING FOR ESOPHAGEAL CANCER IN CHINA
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF ACUPUNCTURE TREATMENT COMPARED TO PLACEBO IN VETERANS WITH COMBAT-RELATED POSTTRAUMATIC STRESS DISORDER (PTSD)
Mar 18, 2026, 21:38 PM
